Cargando…

Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease

Background: Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiest, Maximilian Robert Justus, Toro, Mario Damiano, Nowak, Albina, Bajka, Anahita, Fasler, Katrin, Al-Sheikh, Mayss, Hamann, Timothy, Zweifel, Sandrine Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093750/
https://www.ncbi.nlm.nih.gov/pubmed/37046445
http://dx.doi.org/10.3390/diagnostics13071227
_version_ 1785023661361594368
author Wiest, Maximilian Robert Justus
Toro, Mario Damiano
Nowak, Albina
Bajka, Anahita
Fasler, Katrin
Al-Sheikh, Mayss
Hamann, Timothy
Zweifel, Sandrine Anne
author_facet Wiest, Maximilian Robert Justus
Toro, Mario Damiano
Nowak, Albina
Bajka, Anahita
Fasler, Katrin
Al-Sheikh, Mayss
Hamann, Timothy
Zweifel, Sandrine Anne
author_sort Wiest, Maximilian Robert Justus
collection PubMed
description Background: Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measuring vessel density (VD), vessel length density (VLD), and the ratio of VD to VLD (VD/VLD) in superficial capillary plexuses (SCP) and deep capillary plexuses (DCP) using OCTA in patients with FD and to show whether they differ from healthy controls (HC); Patients and methods: Single-center, retrospective, consecutive cohort study of patients with genetically proven FD. Patients underwent an ophthalmological examination including OCTA. VD, VLD, foveal avascular zone (FAZ), and the VD/VLD were compared to an HC group using a linear mixed model; Results: A statistically significant difference in the VLD and VD/VLD of DCP was observed between the two groups (p < 0.001). Using ROC curves with AUC and Youden’s Index, a cut-off value for differentiating both groups using VD/VLD in DCP FD with high specificity and high sensitivity was established; Conclusions: FD and HC groups seem to be separable using the VD/VLD ratio in DCP. This new biomarker might differentiate changes in the retinal microvasculature that are not detectable by VD or VLD alone.
format Online
Article
Text
id pubmed-10093750
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100937502023-04-13 Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease Wiest, Maximilian Robert Justus Toro, Mario Damiano Nowak, Albina Bajka, Anahita Fasler, Katrin Al-Sheikh, Mayss Hamann, Timothy Zweifel, Sandrine Anne Diagnostics (Basel) Article Background: Fabry disease (FD) is a potentially lethal lysosomal disorder with systemic vascular changes. Previous studies demonstrated retinal vascular involvement using optical coherence tomography angiography (OCTA) in affected patients; Aim: To analyze and quantify the retinal vasculature measuring vessel density (VD), vessel length density (VLD), and the ratio of VD to VLD (VD/VLD) in superficial capillary plexuses (SCP) and deep capillary plexuses (DCP) using OCTA in patients with FD and to show whether they differ from healthy controls (HC); Patients and methods: Single-center, retrospective, consecutive cohort study of patients with genetically proven FD. Patients underwent an ophthalmological examination including OCTA. VD, VLD, foveal avascular zone (FAZ), and the VD/VLD were compared to an HC group using a linear mixed model; Results: A statistically significant difference in the VLD and VD/VLD of DCP was observed between the two groups (p < 0.001). Using ROC curves with AUC and Youden’s Index, a cut-off value for differentiating both groups using VD/VLD in DCP FD with high specificity and high sensitivity was established; Conclusions: FD and HC groups seem to be separable using the VD/VLD ratio in DCP. This new biomarker might differentiate changes in the retinal microvasculature that are not detectable by VD or VLD alone. MDPI 2023-03-24 /pmc/articles/PMC10093750/ /pubmed/37046445 http://dx.doi.org/10.3390/diagnostics13071227 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wiest, Maximilian Robert Justus
Toro, Mario Damiano
Nowak, Albina
Bajka, Anahita
Fasler, Katrin
Al-Sheikh, Mayss
Hamann, Timothy
Zweifel, Sandrine Anne
Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title_full Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title_fullStr Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title_full_unstemmed Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title_short Relationship of Vessel Density to Vessel Length Density in Patients with Treated Fabry Disease
title_sort relationship of vessel density to vessel length density in patients with treated fabry disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093750/
https://www.ncbi.nlm.nih.gov/pubmed/37046445
http://dx.doi.org/10.3390/diagnostics13071227
work_keys_str_mv AT wiestmaximilianrobertjustus relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT toromariodamiano relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT nowakalbina relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT bajkaanahita relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT faslerkatrin relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT alsheikhmayss relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT hamanntimothy relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease
AT zweifelsandrineanne relationshipofvesseldensitytovessellengthdensityinpatientswithtreatedfabrydisease